Avacta Group, the UK developer of Affimer biotherapeutics and research reagents, has opened two new facilities, in Cambridge and Wetherby in the UK.
The new buildings almost double the company’s total footprint, from 9500 to 18500 ft2 (880 m2 to 1700 m2, including new laboratory facilities.
The new laboratories and office space will allow operations at both sites to expand to meet increasing commercial demands and accommodate Avacta’s growing R&D programme.
Around 70% of the new premises in Cambridge is devoted to laboratories
The new Cambridge site is located on the Lion Works Business Park in Whittlesford, and covers 5500 ft2 (510 m2), of which around 70% houses laboratories.
In Wetherby, the Thorp Arch Estate has provided a new 13000 ft2 (1205 m2) building, which Avacta has fitted with offices and laboratories accommodating around 60 people.
Dr Alastair Smith, Chief Executive Officer, Avacta, said: 'I am delighted with the new labs that the company now has in place in Wetherby and Cambridge.
'The teams will be working in truly world class facilities that will also help in attracting talented new staff and will present the company well to potential customers and partners.'